The ∆MSMEG4722 mutant also showed a slightly slower growth rate than the parental mc2155
strain (Figure 2C; the OD600 values at 24h correspond to 2×108 and 107 colony forming units/ ml
for mc2155 and ∆MSMEG4722 respectively). This wasn’t surprising as a similar growth defect
was observed when the homologous gene was deleted in C. glutamicum, and a genome-wide
transposon screen predicted that the loss of the homologous gene in M. tuberculosis would result
in a slow growth phenotype (Lea-Smith et al., 2007; Sassetti et al., 2003). Additionally, when
grown in LB broth, the mutant showed an increased sensitivity to the lipophilic antibiotic
rifampicin (MIC=0.125 μg∕ml) as compared to the parental strain mc2155 (MIC=16 μg∕ml), but
not to hydrophilic antibiotics like isoniazid and ethambutol. Wild type characteristics were
restored on complementation of the ∆MSMEG4722 mutant with plasmid-borne MSMEG4722
indicating that the observed phenotypes in the mutant strain were solely due to the loss of
MSMEG4722 (Figure 2B and C).
The ∆MSMEG4722 mutant failed to synthesize mature mycolic acids
The predicted role of MSMEG4722 in mycolic acid motif formation and the observed changes in
the colony morphology of the ∆MSMEG4722 mutant prompted us to examine mycolic acids in
the mutant strain. If MSMEG4722 was indeed the reductase catalyzing the conversion of the
post Pks13, α-alkyl, β-oxo fatty acyl intermediate, then the ∆MSMEG4722 mutant would be
expected to accumulate this unreduced intermediate of mycolic acid biosynthesis (Figure 1A). A
standard procedure for release of mycolic acids from mycobacteria involves base hydrolysis of
cells using tetrabutyl ammonium hydroxide (TBAH). This is followed by phase-transfer
catalyzed derivatisation using methyl iodide that results in the formation of mycolic acid methyl
More intriguing information
1. The name is absent2. The name is absent
3. Gender and headship in the twenty-first century
4. Estimating the Technology of Cognitive and Noncognitive Skill Formation
5. The name is absent
6. AN ANALYTICAL METHOD TO CALCULATE THE ERGODIC AND DIFFERENCE MATRICES OF THE DISCOUNTED MARKOV DECISION PROCESSES
7. The name is absent
8. Investment and Interest Rate Policy in the Open Economy
9. The name is absent
10. Partner Selection Criteria in Strategic Alliances When to Ally with Weak Partners